The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism	Neurologic Manifestations, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, corticobasal degeneration disorder, cranial nerve neuropathy, eye disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, primary dysautonomia, progressive supranuclear palsy, synucleinopathy, tauopathy	Recruiting	Phase 2	2025-01-10		NCT06162013

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Akershus Universitetssykehus HF	1
Elysium Health	7
Haukeland University Hospital	163
Helse Fonna	20
Helse Forde	7
Helse Møre og Romsdal HF	19
Nevro Arendal AS	1
Nordlandssykehuset HF	22
Oslo University Hospital	327
Sykehuset Ostfold	8
Universitetssykehuset Nord Norge HF	1
Vestre Viken Hospital Trust	60

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Haukeland University Hospital	Bergen	Norway	11
Oslo University Hospital	Oslo	Norway	7
Vestre Viken HF	Drammen	Norway	4